Our Services

Clinical Studies and Research

A brighter future with improved technologies and medications.

The Brain Care Institute’s neurologists are leaders in research. Faculty members of the Division of Child Neurology bring into the Pittsburgh biomedical community more than $1 million in federal corporate and foundation research funding each year.

Research on TSC focuses on early intervention and ways to lessen the impact of developmental delays on day-to-day functioning. Advances in research are resulting in new and improved therapies, with medications such as MTOR inhibitors to alter disease expression in organs. New surgical techniques are being developed to remove lesions and preserve organ function. Improved technology is helping pinpoint the regions of the brain responsible for seizures in certain patients, and is creating new therapies to help control or even stop these seizures.

Read some of the most frequently asked questions regarding Tuberous Sclerosis.

Last Update
April 12, 2012
  • Increase/Decrease Text Size
  • Print This Page
Last Update
April 12, 2012
top